To help you in your daily practice, discover a wide range of information and services for you and your patients.
In this section, discover tools and services available to you and your patients
‘Tumour Lysis syndrome (TLS) risk’ disc
*Click-it started with a pilot in Chronic Lymphocytic Leukaemia. Content created by BHS Lymphoproliferative disease committee. Created in joint partnership with AbbVie.
BHS=Belgian Hematology Society; TLS=tumour lysis syndrome.
AbbVie SA/NV - BE-ABBV-210073 (v3.0) - Sep 2022
You are now leaving the AbbVie Pro Portal and being re-directed to an external website. The information you are about to be referred to may not comply with the Belgium regulatory requirements.
Do you wish to continue?